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endemic for and a reservoir of K. pneumoniae carbapenemases
(KPC) [1,2].
In March 2014, during a period of active surveillance in ﬁve
neonatal intensive care units (NICUs) of Palermo, Italy, three
carbapenem-nonsusceptible isolates of K. pneumoniae (CR-Kp)
were identiﬁed from rectal swabs of three infants admitted to
two different NICUs. The ﬁrst isolate was detected from an
outborn infant admitted at the ﬁrst NICU on March 3; the
second isolate was identiﬁed on March 10 from an infant staying
in the same NICU as a probable secondary colonization case.
Of interest, a carbapenem-nonsusceptible Escherichia coli isolate
was also detected in the rectal swab of the ﬁrst infant. The third
K. pneumoniae isolate was identiﬁed on March 27 from an
outborn infant admitted to a second NICU. Isolation/cohorting
of colonized patients and reinforcement of infection controlClinical Microbiology and Infection © 2014 European Society of Cmeasures were able to interrupt the transmission in both
NICUs, and no further cases were identiﬁed in the following 3
months.
Molecular typing showed that the three K. pneumoniae iso-
lates carried blaKPC-3 and belonged to two different sequence
types (STs), ST307 and ST323 (Table 1). This ﬁnding, along
with the report by Gona et al. [3] of a multiclonal cluster of
cases of colonization and infection by KPC-producing
K. pneumoniae (KPC-Kp) at the Mediterranean Institute for
Transplantation and Advanced Specialized Therapies (ISMETT)
in Palermo, Italy, prompted us to look for a possible spread of
KPC-Kp isolates other than ST258 in the healthcare facilities of
this city.
All the CR-Kp isolates identiﬁed in April and May 2014 by
the microbiology laboratories of the two largest acute general
hospitals of Palermo (ARNAS ‘Civico, Di Cristina & Benfratelli’
and Azienda Ospedaliera ‘Villa Soﬁa-V. Cervello’) were
collected and characterized. Antibiotic susceptibility testing was
performed by the VITEK-2 automated system (bio-Mérieux,
Marcy l’Etoile, France) and the results interpreted according to
the European Committee on Antimicrobial Susceptibility
Testing (EUCAST) breakpoints (http://www.eucast.org/clinical_
breakpoints/).
Polymerase chain reaction (PCR) screening for carbapene-
mase encoding genes of classes A (blaKPC, blaGES), B (blaVIM,
blaIMP, blaNDM) and D (blaOXA-48) for extended-spectrum
β-lactamases encoding genes blaTEM, blaOXA, blaSHV and
blaCTX-M and for plasmid-mediated quinolone resistance
(PMQR) genes qnrA, qnrB and aac(60)-Ib-cr was performed [4].
Multiplex PCRs for the detection of plasmid-mediated 16S RNA
methylase genes (armA, rmtA, rmtB, rmtC, rmtD and npmA) were
also carried out as previously described [5]. The identity of
resistance genes was conﬁrmed by DNA sequence analysis. To
assess clonality, the isolates were submitted to pulsed-ﬁeld gel
electrophoresis (PFGE) after XbaI DNA digestion. Moreover,
multilocus sequence typing (MLST) was performed according to
the protocol described online on the K. pneumoniae MLST
website (http://www.pasteur.fr/recherche/genopole/ PF8/mlst/
Kpneumoniae.html).
Nineteen isolates of CR-Kp from 16 different patients were
identiﬁed in the two hospitals in the period under study. The
main characteristics of the three NICU isolates and 16 further
isolates from the two hospitals, each from an individual patient
or site, are summarized in Table 1. Besides those detected in
the NICUs, most isolates (12/16) were from three adult
intensive care units (ICUs). However, additional isolates were
identiﬁed from four different wards (Table 1). Seven of 16
isolates belonged to ST307, six to ST258 and three to ST273.Clin Microbiol Infect 2015; 21: e15–e17
linical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved
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Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and InfectAll isolates were KPC-3 producers. Moreover, the ST307 iso-
lates as well as the ST323 NICU isolate harboured the blaCTX-M-
15 gene. The array of the PMQR genes differed by ST; indeed,
K. pneumoniae ST307 tested positive for aac(60)-Ib-cr and qnrB,
ST258 for aac(60)-Ib-cr only, ST323 for qnrB only, whereas
ST273 tested negative for the PMQR genes. None of the
K. pneumoniae isolates carried any of the plasmid-mediated 16S
RNA methylase genes tested in this study. The carbapenem-
nonsusceptible E. coli strain from the NICU index case
proved to carry blaKPC-3.
PFGE of KPC-Kp isolates yielded electrophoretic patterns
that coincided with attribution to STs.
All KPC-Kp isolates, except for the ST323 isolate, were
resistant to ciproﬂoxacin. The resistance pattern to amino-
glycosides appeared to be associated to ST; indeed, the isolates
belonging to STs other than ST258 were susceptible to ami-
kacin and resistant to gentamicin, whereas the ST258 isolates
were susceptible to gentamicin but resistant to amikacin
(Table 1). Conversely, nonsusceptibility to tigecycline and
colistin was not related to ST and involved 5 and 12 isolates,
respectively (Table 1). The KPC E. coli strain was susceptible to
cefepime and all non-β-lactams and, except for meropenem,
exhibited lower MIC values for carbapenems compared with
those observed in KPC-Kp isolates (ertapenem, 1 μg/mL; imi-
penem, 4 μg/mL).
Some troublesome considerations arise from our pre-
liminary investigation about the evolving epidemiology of
KPC-Kp in an area that has been previously reported as highly
endemic [6]. First, the monoclonal spread of the successful
pandemic ST258 clone is apparently being replaced by a
simultaneous dissemination of multiple clones of KPC-Kp, a
probable consequence of the horizontal transfer of mobile
genetic elements carrying the blaKPC gene. This is conﬁrmed
by the isolation of a KPC-producing E. coli isolate from a NICU
infant colonized with KPC-Kp ST307. Our ﬁnding conﬁrms a
previous report by Gona et al. [3] about co-carriage of mul-
tiple clones of KPC-Kp including ST307 and KPC–E. coli by
patients admitted to ISMETT, a highly specialized organ
transplant center in Palermo. ST307, in particular, has proved
to have entered different hospitals and wards, including
NICUs. Moreover, it is noteworthy to highlight that
K. pneumoniae ST273 had been identiﬁed in 2011 in two ICUs
of Palermo as a colistin-resistant but carbapenem-susceptible
clone [5].
Second, colistin resistance was shown to be highly prevalent
within KPC-Kp isolates. Treatment with colistin has been
proven to be a major risk factor for the emergence of resis-
tance and the increasing need to use colistin for the treatment
of carbapenem-resistant gram-negative organisms, such as
Enterobacteriaceae and Acinetobacter baumannii, is likely in turnious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21 e15–e17
CMI Letter to the Editor e17driving healthcare-associated emergence and spread of colistin
resistance.
A prospective collection of isolates is ongoing to answer
questions about cross-transmission of multiple clones of KPC-
Kp and consequent clonal expansion, lateral transmission of
mobile genetic resistance determinants or both. Our pre-
liminary data emphasize the increasing difﬁculties in controlling
the spread of KPC-Kp [1].Transparency declarationAll authors report no conﬂicts of interest relevant to this
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